Top

Published in:

01-11-2015 | Endocrine Tumors

Parathyroid Carcinoma: Is It Time for Change?

Author: David F. Schneider, MD, MS

Published in: Annals of Surgical Oncology | Issue 12/2015

Excerpt

Parathyroid carcinoma is a rare etiology for primary hyperparathyroidism, but recurrence and even mortality occur much more frequently in this disease compared with its more common, benign counterparts—adenomas or hyperplasia. Asare et al. study detailing the prognostic factors for parathyroid carcinoma from the National Cancer Data Base (NCDB) provides useful insights into the behavior of this rare disease and changes current surgical dogma on the appropriate treatment.1 …

Asare EA, Sturgeon C, Winchester DJ, Liu L, Palis B, Perrier ND, Evans DB, Winchester DP, Wang TS. Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015. doi:10.1245/s10434-015-4672-3.

Hsu KT, Sippel RS, Chen H, Schneider DF. Is central lymph node dissection necessary for parathyroid carcinoma? Surgery. 2014;156(6):1336–41. doi:10.1016/j.surg.2014.08.005; discussion 41.PubMedCentralCrossRefPubMed

Talat N, Schulte KM. Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol. 2010;17(8):2156–74. doi:10.1245/s10434-010-1003-6.CrossRefPubMed

Title: Parathyroid Carcinoma: Is It Time for Change?
Author: David F. Schneider, MD, MS
Publication date: 01-11-2015
Publisher: Springer US
Published in: Annals of Surgical Oncology / Issue 12/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-015-4673-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Parathyroid Carcinoma: Is It Time for Change?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2015

Preoperative Chronic Kidney Disease Status is an Independent Prognostic Factor in Patients with Renal Cell Carcinoma

Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer

Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma

Factors Implicated for Delay of Adjuvant Chemotherapy in Colorectal Cancer: A Meta-analysis of Observational Studies

Do All Patients Require Prophylactic Drainage After Gastrectomy for Gastric Cancer? The Experience of a High-Volume Center

Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?